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Introduction
• The intent of This poster is 
to discuss the link between 
genetics and depression. 
• Depression is known to be 
related to nature and 
nurture.
• Parents worry about the 
safety and happiness of 
their children, and no 
parents want their child to 
suffer from mental illness, 
especially if the parent 
himself suffers from it. 
• This topic was chosen to 
gain insight on the 
possibility of  psychological 
disorders such as 
depression  being passed  
on to offspring. 
• Depression can be seen in 
multiple generations, but it 
can also affect those with 
no family history. 
Gene Location Name Function
5-HTR2A Chromosome 13 Hydroxytryptamine receptor 2A G-protein-coupled serotonin 
receptor that can activate signal 
transduction inside the cell
5-HTT Chromosome 17 Serotonin transporter protein Transports serotonin from 
synapses to presynaptic 
neurons
BDNF Chromosome11 Brain-derived neurotropic factor Promote the survival of neurons 
by preventing apoptosis 
FGF Chromosome 6 Fibroblast growth factor Important growth factor that 
ameliorates hippocampal 
neurogenesis
IGF Chromosome 12 FK506 binding protein 5 Involved in immunoregulation 
and in the modulation of stress 
and anxiety
TPH2 Chromosome 12 Tryptophan hydroxylase 2 Involved in serotonin synthesis
VEGF Chromosome 6 Vascular endothelial growth 
factor
Increases endothelial cell 
number and promotes 
neurogenesis, neuronal cell 
survival and synaptic plasticity
Table 1
Candidate genes involved in the pathophysiology of MDD.
Fakhoury, 2018
Signs and Symptoms
of Depression.
• Persistent sadness and 
loss of interest, poor 
memory, thoughts of 
suicide and death 
(Fakhoury, 2015). 
• Extreme sadness, 
worthlessness, or 
hopelessness, changes 
in habits, persistent 
fatigue, mood swings, 
difficulty concentrating , 
wanting to be alone  
(Harvard Health Letter, 
2018)
• Depression  is mostly associated 
with environmental factors such 
as stress and trauma, but can be 
caused by genetic, biological, and 
psychological factors (Fakhoury, 
2018).
• Individuals under a large amount 
of stress for a prolonged period of 
time can develop 
hypercortisolemia which can lead 
to symptoms of  depression 
(Sharpley et al., 2018). 
• Stress also causes a reduction in 
the production of the brain-
derived neurotropic factor  
(BDNF) protein that contributes to 
an individual’s ability to think 
clearly, which is another symptom 
of depression (Sharpley et al. 
2018). 
Pathophysiology – Genetics.
• A study by Pettersson et al. (2019) examined the genetic link between siblings and psychological disorders. It was determined that 
common genetics variants play a large role in the development of major depressive disorder (MDD) and other psychiatric disorders.
• While environment may increase the risk of an individual being clinically depressed, genetics contribute greatly as far predisposition to 
being influenced by environment. 
• Personality is linked to a person’s vulnerability as well (Navrady et al., 2018).
• Scientists have discovered a linkage between the 12q23 region of the human genome and the risk of developing MDD (Fakhoury, 
2018). 
• Those with MDD often have an imbalance of multiple neurotropic factors. These neurotropic factors can be seen in Table 1. 
• Each neurotropic factor gene has a different mechanism of action. If the chromosome that the gene resides on is mutated, then the 
gene may be altered, thus altering its function and increasing the risk of the individual exhibiting depressive symptoms (see Table 1). 
• MDD is characterized by an altered level of serotonin (5-HT), and genes that control the synthesis or inhibition have the potential to 
influence the severity of the disorder. 5-HT levels can be altered by the serotonin transporter protein (5-HTT), 5-HT receptors (5-
HTR2A), and tryptophan hydroxylase 2 (TPH2) (Fakhoury, 2018). 
• Additionally, individuals with one or two copies of the short allele of the 5-HTT polymorphism are more likely to be affected by
stressful life events and show more depressive symptoms than those homozygous form the long allele (Fakhoury, 2018). 
• Changes in gene expression have also been linked with MD. For example, “DNA methylation of BDNF is linked to the pathophysiology
of depression due to reduced neural levels of BDNF in the brain” (Fakhoury, 2018, p.173). This can happen as a response to 
environmental influences such as diet and drug use. In sum, environmental factors can alter genetic expression causing depressive 
symptoms. 
Significance.
• The genetic risk for MDD that presents in adulthood 
is higher than that for MDD that presents in 
childhood (Mistry et al., 2018). This is significant 
because it is more likely that it will be unknown if 
the child will develop MDD until he or she reaches 
adulthood thus possibly delaying interventions to 
reduce the severity of the disorder. 
• Additionally, a family history of psychotic illness 
increases the chance of the individual having a more 
severe form of MDD (Mistry et al., 2018) If this is 
well known, earlier treatment options may be 
available as well as the drive for more advanced 
screening tools. These resources could decrease the 
risk for suicide, need for antidepressants, and 
increase the individual’s productivity level. 
• Knowing exactly which genes control depressive 
disorders is essential in the development of 
medications for treatment. For example, SSRIs 
inhibit the reuptake of serotonin and dopamine, and 
serotonin levels are influenced by specifics genes. 
Nursing Implications.
• Nurses could be trained in 
genetic counseling to help 
expecting parents determine the
risk of their child developing a 
depressive disorder.
• Better understanding of the 
cause of depression will lead to 
better understanding of 
effective treatment and 
medications.
• If a nurse understands that the
patient isn’t just “crazy” or 
“emotional”, then treatment will 
be conducted similarly to that of 
physical disorders instead of as 
if it is all in the patient’s head.
• Nurses will be able to better 
educate patient’s about
depression and what has caused 
the patients individual case. 
Conclusion
• In conclusion, depressive disorders are the 
product of environmental, biological, and 
psychological factors. Understanding how 
genetics plays a role in the development and 
progression of depression will facilitate the 
improvement of treatment plans and 
medication. It is known that environmental 
factors can alter genetic factors, therefore it is 
important for nurses and providers to deliver 
proper education to patients, especially 
expecting parents, on the affects of certain life 
choices on mental health. 
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